5 Signs Your EU MDR CER May Attract Notified Body Questions
Before a Notified Body raises formal comments, there are early indicators in your CER that a reviewer may push back. Here is what to watch for.
EU MDR Clinical & Post-Market Regulatory Writing
We help medical device manufacturers turn scattered clinical, PMS, and PMCF evidence into clear, MDR-aligned documentation — including CERs, PSURs, PMCF reports, SSCPs, and Notified Body response packages.
Many medical device teams have the data they need, but the evidence is scattered across CERs, PMS reports, PMCF plans, risk files, complaints, literature reviews, and Notified Body correspondence. We help organise that evidence into clear regulatory narratives that support MDR review, surveillance audits, and clinical documentation updates.
Notified Body comments on CER, PMS, PMCF, or PSUR
Outdated CERs requiring EU MDR remediation
Weak linkage between clinical evidence and benefit-risk conclusions
PMCF plans that feel generic or poorly justified
PMS/PMCF data not feeding back into CER updates
SSCP content that does not align with clinical documentation
What We Do
Specialised regulatory writing for clinical evaluation, post-market documentation, and Notified Body response work under EU MDR.
For medical device teams that need a new, updated, or remediated Clinical Evaluation Report under EU MDR.
For teams that received Notified Body questions on clinical evaluation or post-market documentation.
For companies that need post-market documentation that connects back to the CER and benefit-risk conclusions.
For Class III and implantable devices requiring clear, aligned, and audience-appropriate SSCP content.
CERs, PMS reports, PMCF plans, PSURs, SSCPs, and Notified Body responses should not be written as disconnected documents. They need to tell a consistent clinical evidence story across intended purpose, claims, risks, post-market data, clinical benefits, and benefit-risk conclusions.
Our Approach
We start by understanding the clinical evidence, residual risks, claims, intended purpose, and post-market data before drafting conclusions.
We connect CER, PMS, PMCF, PSUR, SSCP, and risk documentation so the clinical story remains consistent across the technical file.
We write for regulatory reviewers, internal RA/QA teams, clinical stakeholders, and decision-makers — not just for document completion.
Who We Help
We support medical device manufacturers, RA/QA leaders, clinical affairs teams, and regulatory consultants who need focused writing capacity for EU MDR clinical and post-market documentation.
Small and mid-sized medical device manufacturers
RA/QA teams preparing for MDR reviews or surveillance audits
Clinical affairs teams managing CER and PMCF updates
Consultants needing specialist writing support
Class IIa, IIb, III, and implantable device teams
Teams responding to Notified Body questions
Not sure where to start?
Need to understand your documentation gaps before full remediation?
A focused review for medical device teams preparing CER updates, PMCF reports, PSURs, SSCPs, or Notified Body responses. We identify documentation gaps, consistency issues, and priority actions before you invest in full remediation.
Request a Gap ReviewInsights
Before a Notified Body raises formal comments, there are early indicators in your CER that a reviewer may push back. Here is what to watch for.
Not every CER gap requires a full remediation. Understanding the difference between an update and a remediation helps teams prioritise time and budget correctly.
EU MDR requires post-market data to actively inform your Clinical Evaluation Report. This is how to build that feedback loop into your documentation lifecycle.
Ready When You Are
Tell us what you are working on — CER update, PMCF report, PSUR, SSCP, or Notified Body response — and we will help identify the most practical next step.
Get in Touch